Gender differences in the provision of intensive care: a Bayesian approach.


Journal

Intensive care medicine
ISSN: 1432-1238
Titre abrégé: Intensive Care Med
Pays: United States
ID NLM: 7704851

Informations de publication

Date de publication:
05 2021
Historique:
received: 20 11 2020
accepted: 24 03 2021
pubmed: 23 4 2021
medline: 9 6 2021
entrez: 22 4 2021
Statut: ppublish

Résumé

It is currently unclear whether management and outcomes of critically ill patients differ between men and women. We sought to assess the influence of age, sex and diagnoses on the probability of intensive care provision in critically ill cardio- and neurovascular patients in a large nationwide cohort in Switzerland. Retrospective analysis of 450,948 adult patients with neuro- and cardiovascular disease admitted to all hospitals in Switzerland between 01/2012 and 12/2016 using Bayesian modeling. For all diagnoses and populations, median ages at admission were consistently higher for women than for men [75 (64;82) years in women vs. 68 (58;77) years in men, p < 0.001]. Overall, women had a lower likelihood to be admitted to an intensive care unit (ICU) than men, despite being more severely ill [odds ratio (OR) 0.78 (0.76-0.79)]. ICU admission probability was lowest in women aged > 65 years (OR women:men 0.94 (0.89-0.99), p < 0.001). Women < 45 years had a similar ICU admission probability as men in the same age category [OR women:men 1.03 (0.94-1.13)], in spite of more severe illness. The odds to die were significantly higher in women than in men per unit increase in Simplified Acute Physiology Score (SAPS) II (OR 1.008 [1.004-1.012]). In the care of the critically ill, our study suggests that women are less likely to receive ICU treatment regardless of disease severity. Underuse of ICU care was most prominent in younger women < 45 years. Although our study has several limitations that are imposed by the limited data available from the registries, our findings suggest that current ICU triage algorithms could benefit from careful reassessment. Further, and ideally prospective, studies are needed to confirm our findings.

Identifiants

pubmed: 33884452
doi: 10.1007/s00134-021-06393-3
pii: 10.1007/s00134-021-06393-3
pmc: PMC8139895
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

577-587

Subventions

Organisme : Research Foundation in Anesthesiology and Intensive Care Medicine, University Hospital Basel
ID : CEG
Organisme : Research Fund of the University of Basel
ID : CEG
Organisme : Schweizerischer Nationalfonds zur Förderung der Wissenschaftlichen Forschung
ID : CEG
Organisme : Schweizerischer Nationalfonds zur Förderung der Wissenschaftlichen Forschung
ID : CG
Organisme : Olga Mayenfisch Stiftung
ID : CG
Organisme : OPO-Stiftung
ID : CG
Organisme : Novartis Stiftung für Medizinisch-Biologische Forschung
ID : CG
Organisme : Swissheart Foundation
ID : CG
Organisme : Swissheart Foundation
ID : SB
Organisme : Helmut Horten Foundation
ID : CG
Organisme : EMDO Stiftung
ID : CG
Organisme : Iten-Kohaut Foundation/University Hospital Zurich Foundation
ID : CG
Organisme : LOOP-Zurich, Switzerland
ID : CG
Organisme : Swiss Academy of Medical Sciences and the Gottfried and Julia Bangerter-Rhyner-Foundation, Switzerland
ID : KA
Organisme : UZH Foundation, Switzerland
ID : SB
Organisme : UZH Foundation
ID : AH
Organisme : Swiss National Foundation (No 320030_169379)
ID : RS
Organisme : Research Fund of the University Basel
ID : RS
Organisme : Scientific Society Basel
ID : RS
Organisme : Gottfried Julia Bangerter-Rhyner Foundation
ID : RS

Commentaires et corrections

Type : CommentIn

Références

J Crit Care. 2009 Dec;24(4):630.e1-8
pubmed: 19427166
Crit Care Med. 2020 Dec;48(12):e1242-e1250
pubmed: 33031145
Gend Med. 2010 Oct;7(5):422-37
pubmed: 21056869
Lancet. 2020 Aug 22;396(10250):565-582
pubmed: 32828189
Intensive Care Med. 2017 Sep;43(9):1430-1432
pubmed: 28484784
Health Serv Res. 2020 Feb;55(1):35-43
pubmed: 31709536
IEEE Trans Image Process. 2012 Apr;21(4):2160-77
pubmed: 22020684
CMAJ. 2007 Dec 4;177(12):1513-9
pubmed: 18003954
J Am Coll Cardiol. 2014 Jul 29;64(4):337-45
pubmed: 25060366
J Crit Care. 2020 Feb;55:22-27
pubmed: 31683118
Eur Heart J. 2020 Apr 1;41(13):1328-1336
pubmed: 31876924
Sci Rep. 2019 Oct 2;9(1):14222
pubmed: 31578418
Int J Qual Health Care. 2019 Aug 1;31(7):1-7
pubmed: 30608577
Stroke. 2019 Sep;50(9):2299-2306
pubmed: 31412754
Acta Anaesthesiol Scand. 2019 Oct;63(9):1210-1215
pubmed: 31190331
Mayo Clin Proc. 2018 Oct;93(10):1404-1414
pubmed: 30031555
Intensive Care Med. 1997 Jul;23(7):760-5
pubmed: 9290990
JAMA. 1995 Mar 1;273(9):703-8
pubmed: 7853627
Eur Heart J Acute Cardiovasc Care. 2016 Feb;5(1):43-54
pubmed: 25681487
Open Heart. 2017 Nov 14;4(2):e000689
pubmed: 29177059
Scand J Trauma Resusc Emerg Med. 2015 Dec 24;23:108
pubmed: 26702646
Eur Heart J Acute Cardiovasc Care. 2020 Dec;9(8):966-974
pubmed: 31452378
Am J Med. 2017 Nov;130(11):1324.e15-1324.e22
pubmed: 28623174
Arch Intern Med. 1995 Oct 23;155(19):2056-62
pubmed: 7575064
Death Stud. 2001 Mar;25(2):127-49
pubmed: 11708352
Circulation. 2019 Feb 19;139(8):1047-1056
pubmed: 30586725
Ups J Med Sci. 2012 Nov;117(4):415-25
pubmed: 22793786
Circulation. 2020 Mar 3;141(9):e139-e596
pubmed: 31992061
Crit Care. 2015 Mar 30;19:129
pubmed: 25887421
N Engl J Med. 1991 Jul 25;325(4):274-6
pubmed: 2057027
Circulation. 2019 Feb 19;139(8):1057-1059
pubmed: 30779654
JAMA. 1993 Dec 22-29;270(24):2957-63
pubmed: 8254858
J Am Coll Cardiol. 2018 May 8;71(18):1960-1969
pubmed: 29724348
Eur Heart J. 2016 Nov 7;37(42):3232-3245
pubmed: 27523477
Eur Heart J. 2017 Apr 7;38(14):1060-1065
pubmed: 28329052
JACC Heart Fail. 2020 Sep;8(9):770-779
pubmed: 32653446

Auteurs

Atanas Todorov (A)

Intensive Care Unit, University Hospital Basel, Petersgraben 4, 4031, Basel, Switzerland.
Department of Nuclear Medicine, University Hospital Zurich, Zurich, Switzerland.
Center for Molecular Cardiology, University of Zurich, Zurich, Switzerland.

Fabian Kaufmann (F)

Intensive Care Unit, University Hospital Basel, Petersgraben 4, 4031, Basel, Switzerland.

Ketina Arslani (K)

Department of Cardiology, University Hospital Basel, Basel, Switzerland.

Ahmed Haider (A)

Department of Nuclear Medicine, University Hospital Zurich, Zurich, Switzerland.
Center for Molecular Cardiology, University of Zurich, Zurich, Switzerland.

Susan Bengs (S)

Department of Nuclear Medicine, University Hospital Zurich, Zurich, Switzerland.
Center for Molecular Cardiology, University of Zurich, Zurich, Switzerland.

Georg Goliasch (G)

Department of Internal Medicine II, Division of Cardiology, Medical University of Vienna, Vienna, Austria.

Núria Zellweger (N)

Intensive Care Unit, University Hospital Basel, Petersgraben 4, 4031, Basel, Switzerland.

Janna Tontsch (J)

Intensive Care Unit, University Hospital Basel, Petersgraben 4, 4031, Basel, Switzerland.

Raoul Sutter (R)

Intensive Care Unit, University Hospital Basel, Petersgraben 4, 4031, Basel, Switzerland.
Department of Clinical Research, University Hospital Basel, Basel, Switzerland.
University of Basel, Basel, Switzerland.

Bigna Buddeberg (B)

Department of Anesthesiology, University Hospital Basel, Basel, Switzerland.

Alexa Hollinger (A)

Intensive Care Unit, University Hospital Basel, Petersgraben 4, 4031, Basel, Switzerland.
University of Basel, Basel, Switzerland.

Elisabeth Zemp (E)

University of Basel, Basel, Switzerland.
Swiss Tropical and Public Health Institute, Basel, Switzerland.

Mark Kaufmann (M)

Department of Anesthesiology, University Hospital Basel, Basel, Switzerland.

Martin Siegemund (M)

Intensive Care Unit, University Hospital Basel, Petersgraben 4, 4031, Basel, Switzerland.
Department of Clinical Research, University Hospital Basel, Basel, Switzerland.
University of Basel, Basel, Switzerland.

Cathérine Gebhard (C)

Department of Nuclear Medicine, University Hospital Zurich, Zurich, Switzerland.
Center for Molecular Cardiology, University of Zurich, Zurich, Switzerland.

Caroline E Gebhard (CE)

Intensive Care Unit, University Hospital Basel, Petersgraben 4, 4031, Basel, Switzerland. evacaroline.gebhard@usb.ch.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH